메뉴 건너뛰기




Volumn 35, Issue 6, 2016, Pages 714-721

From statistical significance to clinical relevance: A simple algorithm to integrate brain natriuretic peptide and the Seattle Heart Failure Model for risk stratification in heart failure

Author keywords

biomarkers; heart failure; natriuretic peptides; prognosis; risk stratification; Seattle Heart Failure Model

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

EID: 84962185184     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2016.01.016     Document Type: Article
Times cited : (15)

References (33)
  • 1
    • 84884294190 scopus 로고    scopus 로고
    • 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    • C.W. Yancy, M. Jessup, B. Bozkurt, and et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
    • (2013) J Am Coll Cardiol , vol.62 , pp. e147-e239
    • Yancy, C.W.1    Jessup, M.2    Bozkurt, B.3
  • 2
    • 79960702225 scopus 로고    scopus 로고
    • Who has advanced heart failure? Definition and epidemiology
    • O.F. Abouezzeddine, and M.M. Redfield Who has advanced heart failure? Definition and epidemiology Congest Heart Fail 17 2011 160 168
    • (2011) Congest Heart Fail , vol.17 , pp. 160-168
    • Abouezzeddine, O.F.1    Redfield, M.M.2
  • 3
    • 33645827323 scopus 로고    scopus 로고
    • The Seattle Heart Failure Model: Prediction of survival in heart failure
    • W.C. Levy, D. Mozaffarian, D.T. Linker, and et al. The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433
    • (2006) Circulation , vol.113 , pp. 1424-1433
    • Levy, W.C.1    Mozaffarian, D.2    Linker, D.T.3
  • 4
    • 70349779671 scopus 로고    scopus 로고
    • Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population
    • W.C. Levy, K.L. Lee, A.S. Hellkamp, and et al. Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population Circulation 120 2009 835 842
    • (2009) Circulation , vol.120 , pp. 835-842
    • Levy, W.C.1    Lee, K.L.2    Hellkamp, A.S.3
  • 5
    • 78650082665 scopus 로고    scopus 로고
    • Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee
    • E.Z. Gorodeski, E.C. Chu, C.H. Chow, and et al. Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee Circ Heart Fail 3 2010 706 714
    • (2010) Circ Heart Fail , vol.3 , pp. 706-714
    • Gorodeski, E.Z.1    Chu, E.C.2    Chow, C.H.3
  • 6
    • 58249091446 scopus 로고    scopus 로고
    • Utility of the Seattle Heart Failure Model in patients with advanced heart failure
    • A.P. Kalogeropoulos, V.V. Georgiopoulou, G. Giamouzis, and et al. Utility of the Seattle Heart Failure Model in patients with advanced heart failure J Am Coll Cardiol 53 2009 334 342
    • (2009) J Am Coll Cardiol , vol.53 , pp. 334-342
    • Kalogeropoulos, A.P.1    Georgiopoulou, V.V.2    Giamouzis, G.3
  • 7
    • 0034612118 scopus 로고    scopus 로고
    • Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial - The Losartan Heart Failure Survival Study ELITE II
    • B. Pitt, P.A. Poole-Wilson, R. Segal, and et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II Lancet 355 2000 1582 1587
    • (2000) Lancet , vol.355 , pp. 1582-1587
    • Pitt, B.1    Poole-Wilson, P.A.2    Segal, R.3
  • 8
    • 0035818884 scopus 로고    scopus 로고
    • Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
    • J.N. Cohn, and G. Tognoni Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 345 2001 1667 1675
    • (2001) N Engl J Med , vol.345 , pp. 1667-1675
    • Cohn, J.N.1    Tognoni, G.2
  • 9
    • 11144355760 scopus 로고    scopus 로고
    • Targeted anticytokine therapy in patients with chronic heart failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)
    • D.L. Mann, J.J. McMurray, M. Packer, and et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) Circulation 109 2004 1594 1602
    • (2004) Circulation , vol.109 , pp. 1594-1602
    • Mann, D.L.1    McMurray, J.J.2    Packer, M.3
  • 10
    • 13944270337 scopus 로고    scopus 로고
    • Anemia in patients with heart failure: Prevalence and prognostic role in a controlled trial and in clinical practice
    • A.P. Maggioni, C. Opasich, I. Anand, and et al. Anemia in patients with heart failure: prevalence and prognostic role in a controlled trial and in clinical practice J Card Fail 11 2005 91 98
    • (2005) J Card Fail , vol.11 , pp. 91-98
    • Maggioni, A.P.1    Opasich, C.2    Anand, I.3
  • 11
    • 58649087799 scopus 로고    scopus 로고
    • Incremental value of renal function in risk prediction with the Seattle Heart Failure Model
    • G. Giamouzis, A.P. Kalogeropoulos, V.V. Georgiopoulou, and et al. Incremental value of renal function in risk prediction with the Seattle Heart Failure Model Am Heart J 157 2009 299 305
    • (2009) Am Heart J , vol.157 , pp. 299-305
    • Giamouzis, G.1    Kalogeropoulos, A.P.2    Georgiopoulou, V.V.3
  • 12
    • 13944273412 scopus 로고    scopus 로고
    • Usefulness of depression to predict time to combined end point of transplant or death for outpatients with advanced heart failure
    • M.D. Sullivan, W.C. Levy, B.A. Crane, and et al. Usefulness of depression to predict time to combined end point of transplant or death for outpatients with advanced heart failure Am J Cardiol 94 2004 1577 1580
    • (2004) Am J Cardiol , vol.94 , pp. 1577-1580
    • Sullivan, M.D.1    Levy, W.C.2    Crane, B.A.3
  • 13
    • 79952114286 scopus 로고    scopus 로고
    • Predictive value of the Seattle Heart Failure Model in patients undergoing left ventricular assist device placement
    • E.S. Ketchum, A.J. Moorman, D.P. Fishbein, and et al. Predictive value of the Seattle Heart Failure Model in patients undergoing left ventricular assist device placement J Heart Lung Transplant 29 2010 1021 1025
    • (2010) J Heart Lung Transplant , vol.29 , pp. 1021-1025
    • Ketchum, E.S.1    Moorman, A.J.2    Fishbein, D.P.3
  • 14
    • 61849144362 scopus 로고    scopus 로고
    • Can the Seattle Heart Failure Model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy?
    • W.C. Levy, D. Mozaffarian, D.T. Linker, and et al. Can the Seattle Heart Failure Model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy? J Heart Lung Transplant 28 2009 231 236
    • (2009) J Heart Lung Transplant , vol.28 , pp. 231-236
    • Levy, W.C.1    Mozaffarian, D.2    Linker, D.T.3
  • 15
    • 84863903886 scopus 로고    scopus 로고
    • Breathing not properly 10 years later: What we have learned and what we still need to learn
    • A.S. Maisel, and L.B. Daniels Breathing not properly 10 years later: what we have learned and what we still need to learn J Am Coll Cardiol 60 2012 277 282
    • (2012) J Am Coll Cardiol , vol.60 , pp. 277-282
    • Maisel, A.S.1    Daniels, L.B.2
  • 17
    • 34547652987 scopus 로고    scopus 로고
    • Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding b-type natriuretic peptide
    • H.T. May, B.D. Horne, W.C. Levy, and et al. Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding b-type natriuretic peptide Am J Cardiol 100 2007 697 700
    • (2007) Am J Cardiol , vol.100 , pp. 697-700
    • May, H.T.1    Horne, B.D.2    Levy, W.C.3
  • 18
    • 84860797764 scopus 로고    scopus 로고
    • Multiple biomarkers for risk prediction in chronic heart failure
    • B. Ky, B. French, W.C. Levy, and et al. Multiple biomarkers for risk prediction in chronic heart failure Circ Heart Fail 5 2012 183 190
    • (2012) Circ Heart Fail , vol.5 , pp. 183-190
    • Ky, B.1    French, B.2    Levy, W.C.3
  • 19
    • 84886289237 scopus 로고    scopus 로고
    • Prealbumin improves death risk prediction of BNP-added seattle heart failure model: Results from a pilot study in elderly chronic heart failure patients
    • A. Cabassi, J. de Champlain, U. Maggiore, and et al. Prealbumin improves death risk prediction of bnp-added seattle heart failure model: results from a pilot study in elderly chronic heart failure patients Int J Cardiol 168 2013 3334 3339
    • (2013) Int J Cardiol , vol.168 , pp. 3334-3339
    • Cabassi, A.1    De Champlain, J.2    Maggiore, U.3
  • 20
    • 33750726707 scopus 로고    scopus 로고
    • Systolic and diastolic heart failure in the community
    • F. Bursi, S.A. Weston, M.M. Redfield, and et al. Systolic and diastolic heart failure in the community JAMA 296 2006 2209 2216
    • (2006) JAMA , vol.296 , pp. 2209-2216
    • Bursi, F.1    Weston, S.A.2    Redfield, M.M.3
  • 21
    • 0037130155 scopus 로고    scopus 로고
    • Rapid measurement of b-type natriuretic peptide in the emergency diagnosis of heart failure
    • A.S. Maisel, P. Krishnaswamy, R.M. Nowak, and et al. Rapid measurement of b-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
    • (2002) N Engl J Med , vol.347 , pp. 161-167
    • Maisel, A.S.1    Krishnaswamy, P.2    Nowak, R.M.3
  • 22
    • 0037019567 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide concentration: Impact of age and gender
    • M.M. Redfield, R.J. Rodeheffer, S.J. Jacobsen, and et al. Plasma brain natriuretic peptide concentration: impact of age and gender J Am Coll Cardiol 40 2002 976 982
    • (2002) J Am Coll Cardiol , vol.40 , pp. 976-982
    • Redfield, M.M.1    Rodeheffer, R.J.2    Jacobsen, S.J.3
  • 23
    • 3142745348 scopus 로고    scopus 로고
    • Trends in heart failure incidence and survival in a community-based population
    • V.L. Roger, S.A. Weston, M.M. Redfield, and et al. Trends in heart failure incidence and survival in a community-based population JAMA 292 2004 344 350
    • (2004) JAMA , vol.292 , pp. 344-350
    • Roger, V.L.1    Weston, S.A.2    Redfield, M.M.3
  • 24
    • 79952309013 scopus 로고    scopus 로고
    • Loss-of-function DNA sequence variant in the clcnka chloride channel implicates the cardio-renal axis in interindividual heart failure risk variation
    • T.P. Cappola, S.J. Matkovich, W. Wang, and et al. Loss-of-function DNA sequence variant in the clcnka chloride channel implicates the cardio-renal axis in interindividual heart failure risk variation Proc Natl Acad Sci USA 108 2011 2456 2461
    • (2011) Proc Natl Acad Sci USA , vol.108 , pp. 2456-2461
    • Cappola, T.P.1    Matkovich, S.J.2    Wang, W.3
  • 25
    • 68249087127 scopus 로고    scopus 로고
    • Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure
    • B. Ky, S.E. Kimmel, R.N. Safa, and et al. Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure Circulation 120 2009 310 317
    • (2009) Circulation , vol.120 , pp. 310-317
    • Ky, B.1    Kimmel, S.E.2    Safa, R.N.3
  • 26
    • 14544292879 scopus 로고    scopus 로고
    • Quality specifications for b-type natriuretic peptide assays
    • F.S. Apple, M. Panteghini, J. Ravkilde, and et al. Quality specifications for b-type natriuretic peptide assays Clin Chem 51 2005 486 493
    • (2005) Clin Chem , vol.51 , pp. 486-493
    • Apple, F.S.1    Panteghini, M.2    Ravkilde, J.3
  • 28
    • 0020524559 scopus 로고
    • A method of comparing the areas under receiver operating characteristic curves derived from the same cases
    • J.A. Hanley, and B.J. McNeil A method of comparing the areas under receiver operating characteristic curves derived from the same cases Radiology 148 1983 839 843
    • (1983) Radiology , vol.148 , pp. 839-843
    • Hanley, J.A.1    McNeil, B.J.2
  • 29
    • 38849091997 scopus 로고    scopus 로고
    • Evaluating the added predictive ability of a new marker: From area under the roc curve to reclassification and beyond
    • M.J. Pencina, R.B. DAgostino Sr, R.B. DAgostino Jr, and et al. Evaluating the added predictive ability of a new marker: From area under the roc curve to reclassification and beyond Stat Med 27 2008 157 172
    • (2008) Stat Med , vol.27 , pp. 157-172
    • Pencina, M.J.1    Agostino, R.B.D.2    Agostino, R.B.D.3
  • 30
    • 78649477601 scopus 로고    scopus 로고
    • Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
    • M.J. Pencina, R.B. DAgostino Sr, and E.W. Steyerberg Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers Stat Med 30 2011 11 21
    • (2011) Stat Med , vol.30 , pp. 11-21
    • Pencina, M.J.1    Agostino, R.B.D.2    Steyerberg, E.W.3
  • 31
    • 66349111734 scopus 로고    scopus 로고
    • Criteria for evaluation of novel markers of cardiovascular risk: A scientific statement from the American Heart Association
    • M.A. Hlatky, P. Greenland, D.K. Arnett, and et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association Circulation 119 2009 2408 2416
    • (2009) Circulation , vol.119 , pp. 2408-2416
    • Hlatky, M.A.1    Greenland, P.2    Arnett, D.K.3
  • 32
    • 32644436929 scopus 로고    scopus 로고
    • B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: Comparison between systolic and diastolic heart failure
    • Y. Iwanaga, I. Nishi, S. Furuichi, and et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure J Am Coll Cardiol 47 2006 742 748
    • (2006) J Am Coll Cardiol , vol.47 , pp. 742-748
    • Iwanaga, Y.1    Nishi, I.2    Furuichi, S.3
  • 33
    • 78751526447 scopus 로고    scopus 로고
    • Mechanisms involved in increased plasma brain natriuretic peptide after heart transplantation
    • S. Talha, A. Charloux, I. Enache, and et al. Mechanisms involved in increased plasma brain natriuretic peptide after heart transplantation Cardiovasc Res 89 2011 273 281
    • (2011) Cardiovasc Res , vol.89 , pp. 273-281
    • Talha, S.1    Charloux, A.2    Enache, I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.